NCT04610814View on ClinicalTrials.gov

Blood Transfusion by Boston MedFlight Registry

UnknownOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Hemorrhagic Shock
Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital, Boston

Sponsors
All Listed Sponsors
collaborator

Boston MedFlight

UNKNOWN

collaborator

Boston Medical Center

OTHER

collaborator

Tufts Medical Center

OTHER

collaborator

Lahey Clinic

OTHER

collaborator

Beth Israel Deaconess Medical Center

OTHER

lead

Massachusetts General Hospital

OTHER